✦ LIBER ✦

Prospectives on the treatment of chronic hepatitis B and chronic hepatitis C with thymic peptides and antiviral agents

✍ Scribed by Milton G. Mutchnick; Murray N. Ehrinpreis; Joseph L. Kinzie; Rene R. Peleman

Book ID: 118393395
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 854 KB
Volume: 24
Category: Article
ISSN: 0166-3542
DOI: 10.1016/0166-3542(94)90071-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Schistosomiasis and antiviral treatment

Schistosomiasis and antiviral treatment of chronic hepatitis C

✍ Vito Di Marco; Marcello Capra; Francesco Gagliardotto; Donatella Ferraro; Rosa D 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

The meta-analysis of propranolol compared with endoscopic variceal ligation for primary prophylaxis of variceal bleeding by Imperiale and Chalasani 1 favors pharmacotherapy despite the fact that "none of the trials measured the hemodynamic response to propranolol." "Blind beta blockade" is the admin

Thymic factor X treatment of chronic hep

Thymic factor X treatment of chronic hepatitis B

✍ Janusz Cianciara; Tomasz Laskus 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB

We read with interest the report of Mutchnick et al. 1 I on the effectiveness of thymosin therapy for chronic hepatitis B. Both in this paper and in the accompanying editorial (2), the authors cite the study by Dabrowslu et al. (31, which described the ability of thymic factor X (TFX), an extract of

Chronic Hepatitis B and C – current trea

Chronic Hepatitis B and C – current treatment and future therapeutic prospects

✍ Christian Müller 📂 Article 📅 2006 🏛 Springer Vienna 🌐 German ⚖ 75 KB

Review of direct-acting antiviral agents

Review of direct-acting antiviral agents for the treatment of chronic hepatitis C

✍ Shah, Nihar; Pierce, Tracey; Kowdley, Kris V 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 423 KB

The effects of antiviral agents on serum

The effects of antiviral agents on serum hepatitis B e antigen levels in chronic type B hepatitis

✍ KIYOHIKO KURAI; SHIRO IINO; KAZUHIKO KOIKE; KEIJI MITAMURA; YASUO ENDO; HIROSHI 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 641 KB

Economic modeling of treatment in chroni

Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: Promises and limitations

✍ Raymond S. Koff; Leonard B. Seeff 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 411 KB

The past 3 decades have witnessed remarkable advances in knowledge about viral hepatitis. We have moved from the belief, before the early 1970s, that only two vaguely defined viruses existed (infectious and serum; A and B) to the identification by the mid-1990s of six cloned hepatitis agents (A thro